References
- 1. Chen W, Plewig G. Human demodicosis: Revisit and a proposed classification. Br J Dermatol. 2014;170(6):1219-25.10.1111/bjd.12850
- 2. Powell F. Rosacea. In: Griffiths G, Barker J, Bleiker T, et. al., editors. Rook’s Textbook of Dermatology. Ninth. Chichester: John Wiley&Sons Ltd; 2016: 91.1-91.19.
- 3. Asai Y, Tan J, Baibergenova A, Barankin B, Cochrane CL, Humphrey S, et al. Canadian clinical practice guidelines for rosacea. J Cutan Med Surg 2016 Sep 1;20(5):432-45.10.1177/1203475416650427
- 4. Tan J, Berg M. Rosacea: Current state of epidemiology. J Am Acad Dermatol [Internet]. 2013;69(6 SUPPL.1):27-35.10.1016/j.jaad.2013.04.043
- 5. Chosidow O, Cribier B. Epidemiology of rosacea: Updated data. In: Ann Dermatol Venereol. Elsevier Masson; 2011:179-83.10.1016/S0151-9638(11)70087-4
- 6. Two AM, Wu W, Gallo RL, Hata TR. Rosacea: Part I. Introduction, categorization, histology, pathogenesis, and risk factors. J Am Acad Dermatol. 2015 May 1;72(5):749-58.10.1016/j.jaad.2014.08.02825890455
- 7. Ozbagcivan O, Ozturk T, Akarsu S, Ilknur T, Fetil E. Evaluation of metabolic syndrome and its components in patients with rosacea: A cross-sectional, case-control study. Hong Kong J Dermatol. 2020;28(2):55-62.
- 8. Searle T, Al-Niaimi F, Ali FR. Rosacea and the cardiovascular system. Vol. 19, J Cosmet Dermatol. Blackwell Publishing Ltd; 2020:2182-7.10.1111/jocd.1358732621366
- 9. Abram K, Silm H, Maaroos HI, Oona M. Risk factors associated with rosacea. J Eur Acad Dermatol Venereol. 2010;24(5):565-71.10.1111/j.1468-3083.2009.03472.x19874433
- 10. Chen Q, Shi X, Tang Y, Wang B, Xie H fu, Shi W, et al. Association between rosacea and cardiometabolic disease: A systematic review and meta-analysis. J Am Acad Dermatol. 2020 Nov 1;83(5):1331-40.10.1016/j.jaad.2020.04.11332360724
- 11. Forton FMN. Papulopustular rosacea, skin immunity and Demodex: Pityriasis folliculorum as a missing link. J Eur Acad Dermatol Venereol. 2012;26(1):19-28.10.1111/j.1468-3083.2011.04310.x22017468
- 12. Forton FMN. The Pathogenic Role of Demodex Mites in Rosacea: A Potential Therapeutic Target Already in Erythematotelangiectatic Rosacea? Vol. 10, Dermatology and Therapy. Adis; 2020:1229-53.10.1007/s13555-020-00458-9764919033095403
- 13. Forton FMN. Elucidating the role of Demodex folliculorum in the pathogenesis of rosacea: exciting first steps…. Br J Dermatol. 2018;179(2):252-3.
- 14. Forton F, de Maertelaer V. Erythematotelangiectatic rosacea and subclinical demodicosis. Br J Dermatol. 2019;181(4):101-101.10.1111/bjd.18397
- 15. Forton FMN, de Maertelaer V. Rosacea and demodicosis: Little-known diagnostic signs and symptoms. Acta Derm Venereol. 2018;99(1):47-52.
- 16. Forton FMN, de Maertelaer V. Two consecutive standardized skin surface biopsies: An improved sampling method to evaluate demodex density as a diagnostic tool for rosacea and demodicosis. Acta Derm Venereol. 2017;97(2):242-8.10.2340/00015555-252827573185
- 17. Forton FMN, de Maertelaer V. Treatment of rosacea and demodicosis with benzyl benzoate: effects of different doses on Demodex density and clinical symptoms. J Eur Acad Dermatol Venereol. 2019; 34(2):365-9.
- 18. Forton FMN, de Maertelaer V. Papulopustular rosacea and rosacea-like demodicosis: two phenotypes of the same disease? J Eur Acad Dermatol Venereol. 2018 Jun 1;32(6):1011-6.10.1111/jdv.14885600180829478301
- 19. Forton F, Germaux MA, Brasseur T, de Liever A, Laporte M, Mathys C, et al. Demodicosis and rosacea: Epidemiology and significance in daily dermatologic practice. J J Am Acad Dermatol. 2005;52(1):74-87.10.1016/j.jaad.2004.05.03415627084
- 20. Tas Cengiz Z, Ozkol HU, Beyhan YE, Ozturk M, Yilmaz H. Evaluation of some chronical diseases in etiopathogenesis of demodicosis. Dermatologica Sin. 2017;35(4):173-6.10.1016/j.dsi.2017.04.006
- 21. Belli AA, Gok SO, Akbaba G, Etgu F, Dogan G. The relationship between rosacea and insulin resistance and metabolic syndrome. Eur J Dermatol. 2016;26(3):260-4.10.1684/ejd.2016.274827328660
- 22. Petersmann A, Müller-Wieland D, Müller UA, Landgraf R, Nauck M, Freckmann G, et al. Definition, Classification and Diagnosis of Diabetes Mellitus. Exp. Clin. Endocrinol. Diabetes. 2019;127(Suppl 1):1-7.10.1055/a-1018-907831860923
- 23. Tucker LA. Limited Agreement between Classifications of Diabetes and Prediabetes Resulting from the OGTT, Hemoglobin A1c, and Fasting Glucose Tests in 7412 U.S. Adults. J Clin Med. 2020;9(7):1-18.10.3390/jcm9072207740866732668564
- 24. Sánchez-García A, Rodríguez-Gutiérrez R, Mancillas-Adame L, González-Nava V, Díaz González-Colmenero A, Solis RC, et al. Diagnostic Accuracy of the Triglyceride and Glucose Index for Insulin Resistance: A Systematic Review. Int J Endocrinol. 2020;2020:1-7.10.1155/2020/4678526708584532256572
- 25. Altemani A, Alamri A, Ahmed M, al Garbo M, Alharbi T, Al-Rasheed R, et al. Prediabetes and serum insulin levels. Int JComm Med Pub H. 2018;5(5):1684-9.10.18203/2394-6040.ijcmph20181494
- 26. Hay RJ. Demodex and skin disease - False creation or palpable form? Vol. 170, Br J Dermatol. Blackwell Publishing Ltd; 2014. p. 1214-5.10.1111/bjd.1301524947148
- 27. Lacey N, Ní Raghallaigh S, Powell FC. Demodex mites - Commensals, parasites or mutualistic organisms?, Dermatol. 2011;22(2): 128-30.10.1159/00032300921228556
- 28. Lacey N, Russell-Hallinan A, Powell FC. Study of Demodex mites: Challenges and Solutions. J Eur Acad Dermatol Venereol. 2016;30(5):764-75.10.1111/jdv.1351726695086
- 29. Friedman P, Cohen Sabban E, Cabo H. Usefulness of dermoscopy in the diagnosis and monitoring treatment of demodicidosis. Dermatol Pract Concept. 2017;7(1):35-8.10.5826/dpc.0701a06531503828243492
- 30. Hsu CK, Hsu MML, Lee JYY. Demodicosis: A clinicopathological study. J Am Acad Dermatol [Internet]. 2009;60(3):453-62.10.1016/j.jaad.2008.10.05819231642
- 31. García-Vargas A, Mayorga-Rodríguez JA, Sandoval-Tress C. Scalp demodicidosis mimicking favus in a 6-year-old boy. J Am Acad Dermatol. 2007;57(2):19-21.10.1016/j.jaad.2006.04.08217637363
- 32. Fernandez-Flores A, Alija A. Scalp folliculitis with Demodex: Innocent observer or pathogen? Vol. 13, Braz J Infect Dis. 2009. p. 81-2.10.1590/S1413-8670200900020000120140347
- 33. Sanfilippo AM, English JC. Resistant scalp folliculitis secondary to Demodex infestation. Cutis.2005;76:321-4.
- 34. Chuprov AD, Malgina EK. Modern aspects of etiopathogenetic treatment of ophthalmodemodicosis (literature review). Oftalmologiya.2018;15:281-5.10.18008/1816-5095-2018-2S-281-285
- 35. Huang Y, He H, Sheha H, Tseng SCG. Ocular demodicosis as a risk factor of pterygium recurrence. Ophthalmol. 2013;120(7):1341-7.10.1016/j.ophtha.2013.01.00123664471
- 36. Gao YY, Xu DL, Huang LJ, Wang R, Tseng SCG. Treatment of ocular itching associated with ocular demodicosis by 5% tea tree oil ointment. Cornea. 2012;31(1):14-7.10.1097/ICO.0b013e31820ce56c21955627
- 37. Cheng AMS, Sheha H, Tseng SCG. Recent advances on ocular Demodex infestation. Curr Opin Ophthalmol. 2015;26(4):295-300.10.1097/ICU.000000000000016826058028
- 38. Ewald B, Mrowietz U. Bilateral demodicosis of the nipple-areola complex. J Dtsch Dermatol Ges. 2019;17(7):733-4.10.1111/ddg.1384431012997
- 39. Douglas A, Zaenglein AL. A case series of demodicosis in children. Pediatr Dermatol. 2019;36(5):651-4.10.1111/pde.1385231197860
- 40. Álvarez-Salafranca M, Vicente A, Prat Torres C, Combalia A, Monsonís M, Celis-Passini VP, et al. Demodicosis in two patients with a previous history of Langerhans cell histiocytosis. Pediatr Dermatol. 2017;34(6):299-301.10.1111/pde.1328628940244
- 41. Ference BA, Ginsberg HN, Graham I, Ray KK, Packard CJ, Bruckert E, et al. Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel. European Heart Journal. 2017;38(32):2459-71.10.1093/eurheartj/ehx144583722528444290
- 42. Rainer BM, Kang S, Chien AL. Rosacea: Epidemiology, pathogenesis, and treatment. Derm.-Endocrinol. 2017;9(1):1938-72.
- 43. Li Y, Guo L, Hao D, Li X, Wang Y, Jiang X. Association between Rosacea and Cardiovascular Diseases and Related Risk Factors: A Systematic Review and Meta-Analysis. Biomed Res Int. 2020;2020:1-11.10.1155/2020/7015249732028532685519
- 44. Katsambas A, Dessinioti C. The changing faces of acne, rosacea, and hidradenitis suppurativa. Clin Dermatol. 2017;35 (2):114-7.10.1016/j.clindermatol.2016.10.00228274347
- 45. Ünal E, Güvendi Akçınar U, Arduç A. Hidradenitis Suppurativa, Metabolic Syndrome, and Demodex spp. Infestation. Turkiye Parazitol Derg. 2018; 42(2):171-4.
- 46. Tang Q, Li X, Song P, Xu L. Optimal cut-off values for the homeostasis model assessment of insulin resistance (HOMA-IR) and pre-diabetes screening: Developments in research and prospects for the future. Drug Discov Ther. 2015;9(6):380-5.10.5582/ddt.2015.0120726781921
- 47. Alberti KGMM, Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI, Donato KA, et al. Harmonizing the metabolic syndrome: A joint interim statement of the international diabetes federation task force on epidemiology and prevention; National heart, lung, and blood institute; American heart association; World heart federation; International. Circulation. 2009;120(16):1640-5.10.1161/CIRCULATIONAHA.109.19264419805654
- 48. Brož J, Malinovská J, Nunes MA, Kučera K, Rožeková K, Žejglicová K, et al. Prevalence of diabetes and prediabetes and its risk factors in adults aged 25–64 in the Czech Republic: A cross-sectional study. Diabetes Res Clin Pract 2020; 170:108470.10.1016/j.diabres.2020.10847032998019
- 49. Chen YH, Lee YC, Tsao YC, Lu MC, Chuang HH, Yeh WC, et al. Association between high-fasting insulin levels and metabolic syndrome in non-diabetic middle-aged and elderly populations: A community-based study in Taiwan. BMJ Open. 2018;8(5):1-7.10.1136/bmjopen-2017-016554594246829724734